Charles Conroy, Nucleus RadioPharma CEO

Mayo Clin­ic-backed Nu­cle­us Ra­dio­Phar­ma rais­es $56M in Se­ries A to boost CD­MO ser­vices

Nu­cle­us Ra­dio­Phar­ma is mak­ing a splash with an over­sub­scribed $56 mil­lion Se­ries A to prop up the CD­MO’s man­u­fac­tur­ing ca­pac­i­ty, with a Rochester, MN site ex­pect­ed to be com­plet­ed by the end of the year. The raise will al­so be used to fund the con­struc­tion of two re­gion­al hubs, as well as in­crease its re­search and sup­ply chain ca­pa­bil­i­ties.

“We could have gone larg­er, we just de­cid­ed to stop,” Nu­cle­us CEO Charles Con­roy told End­points News in an in­ter­view. “The sci­ence is very well-proven — the sup­port struc­ture is just not in place to make sure we can get it to pa­tients,” he added.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.